Insulin suppresses MPP⁺-induced neurotoxicity by targeting integrins and syndecans in C6 astrocytes

References

• Ramalingam M, Kim S-J. Reactive oxygen/nitrogen species and their functional correlations in neurodegenerative diseases. J Neural Transm (Vienna). 2012;119:891–910.
   PubMed Web of Science ®Google Scholar
• Williams ZR, Goodman CB, Soliman KF. Anaerobic glycolysis protection against 1-methy-4-phenylpyridinium (MPP+) toxicity in C6 glioma cells. Neurochem Res. 2007;32:1071–1080.
   PubMed Web of Science ®Google Scholar
• Forno LS, DeLanney LE, Irwin I, et al. Astrocytes and Parkinson’s disease. Prog Brain Res. 1992;94:429–436.
   PubMed Web of Science ®Google Scholar
• Ramalingam M, Kim S-J. The protective effects of insulin on hydrogen peroxide-induced oxidative stress in C6 glial cells. Biomol Ther. 2009;17:395–402.
   Web of Science ®Google Scholar
• Marongiu ME, Piccardi MP, Bernardi F, et al. Evaluation of the toxicity of the dopaminergic neurotoxins MPTP and MPP+ in PC12 pheochromocytoma cells: binding and biological studies. Neurosci Lett. 1988;94:349–354.
   PubMed Web of Science ®Google Scholar
• Ramalingam M, Kim S-J. The neuroprotective role of insulin against MPP(+)-induced Parkinson’s disease in differentiated SH-SY5Y cells. J Cell Biochem. 2016;117:917–926.
   PubMed Web of Science ®Google Scholar
• Ramalingam M, Kim S-J. Protective effects of activated signaling pathways by insulin on C6 glial cell model of MPP+-induced Parkinson’s disease. J Recept Signal Transduct. 2017;37:100–107.
   PubMed Web of Science ®Google Scholar
• Cao BJ, Reith ME. Nitric oxide inhibits uptake of dopamine and N-methyl-4-phenylpyridinium (MPP+) but not release of MPP+ in rat C6 glioma cells expressing human dopamine transporter. Br J Pharmacol. 2002;137:1155–1162.
   PubMed Web of Science ®Google Scholar
• Klionsky DJ. Autophagy: from phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol. 2007;8:931–937.
   PubMed Web of Science ®Google Scholar
• Morgan MR, Humphries MJ, Bass MD. Synergistic control of cell adhesion by integrins and syndecans. Nat Rev Mol Cell Biol. 2007;8:957–969.
   PubMed Web of Science ®Google Scholar
• Bellin RM, Kubicek JD, Frigault MJ, et al. Defining the role of syndecan-4 in mechanotransduction using surface-modification approaches. Proc Natl Acad Sci U S A. 2009;106:22102–22107.
   PubMed Web of Science ®Google Scholar
• Yoon SH, Ramalingam M, Kim S-J. Insulin stimulates integrin-linked kinase in UMR-106 cells: potential role of heparan sulfate on syndecan-1. J Recept Signal Transduct. 2015;35:613–617.
   PubMed Web of Science ®Google Scholar
• Sheppard D. Roles of alphav integrins in vascular biology and pulmonary pathology. Curr Opin Cell Biol. 2004;16:552–527.
   PubMed Web of Science ®Google Scholar
• Nakanishi T, Kadomatsu K, Okamoto T, et al. Expression of syndecan-1 and -3 during embryogenesis of the central nervous system in relation to binding with midkine. J Biochem. 1997;121:197–205.
   PubMed Web of Science ®Google Scholar
• Ramalingam M, Kim S-J. Mechanisms of action of brain insulin against neurodegenerative diseases. J Neural Transm (Vienna). 2014;121:611–626.
   PubMed Web of Science ®Google Scholar
• Liu B, Gao HM, Wang JY, et al. Role of nitric oxide in inflammation-mediated neurodegeneration. Ann N Y Acad Sci. 2002;962:318–331.
   PubMed Web of Science ®Google Scholar
• Niranjan R, Nath C, Shukla R. The mechanism of action of MPTP-induced neuroinflammation and its modulation by melatonin in rat astrocytoma cells, C6. Free Radic Res. 2010;44:1304–1316.
   PubMed Web of Science ®Google Scholar
• Liang X, Wu L, Wang Q, et al. Function of COX-2 and prostaglandins in neurological disease. J Mol Neurosci. 2007;33:94–99.
   PubMed Web of Science ®Google Scholar
• Hsieh YC, Mounsey RB, Teismann P. MPP(+)-induced toxicity in the presence of dopamine is mediated by COX-2 through oxidative stress. Naunyn Schmiedebergs Arch Pharmacol. 2011;384:157–167.
   PubMed Web of Science ®Google Scholar
• Woodgett JR. cDNA cloning and properties of glycogen synthase kinase-3. Meth Enzymol. 1991;200:564–577.
   PubMed Web of Science ®Google Scholar
• Hur EM, Zhou FQ. GSK3 signalling in neural development. Nat Rev Neurosci. 2010;11:539–551.
   PubMed Web of Science ®Google Scholar
• Schattenberg JRM, Wang YJ, Singh R, et al. Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling. J Biol Chem. 2005;280:9887–9894.
   PubMed Web of Science ®Google Scholar
• Cohen P, Frame S. The renaissance of GSK3. Nat Rev Mol Cell Biol. 2001;2:769–776.
   PubMed Web of Science ®Google Scholar
• Cross DAE, Alessi DR, Cohen P, et al. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995;378:785–789.
   PubMed Web of Science ®Google Scholar
• Yu SW, Baek SH, Brennan RT, et al. Autophagic death of adult hippocampal neural stem cells following insulin withdrawal. Stem Cells. 2008;26:2602–2610.
   PubMed Web of Science ®Google Scholar
• Ren Y, Huang F, Liu Y, et al. Autophagy inhibition through PI3K/Akt increases apoptosis by sodium selenite in NB4 cells. BMB Rep. 2009;42:599–604.
   PubMed Web of Science ®Google Scholar
• Becchetti A, Pillozzi S, Morini R, et al. New insights into the regulation of ion channels by integrins. Int Rev Cell Mol Biol. 2010;279:135–190.
   PubMed Web of Science ®Google Scholar
• Williams AS, Kang L, Wasserman DH. The extracellular matrix and insulin resistance. Trends Endocrinol Metab. 2015;26:357–366.
   PubMed Web of Science ®Google Scholar
• Delcommenne M, Tan C, Gray V, et al. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci U S A. 1998;95:11211–11216.
   PubMed Web of Science ®Google Scholar
• Grimes CA, Jope RS. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol. 2001;65:391–426.
   PubMed Web of Science ®Google Scholar
• Yoshimura T, Kawano Y, Arimura N, et al. GSK-3beta regulates phosphorylation of CRMP-2 and neuronal polarity. Cell 2005;120:137–149.
   PubMed Web of Science ®Google Scholar
• Barczyk M, Carracedo S, Gullberg D. Integrins. Cell Tissue Res. 2010;339:269–280.
   PubMed Web of Science ®Google Scholar
• Koutsioumpa M, Polytarchou C, Courty J, et al. Interplay between αvβ3 integrin and nucleolin regulates human endothelial and glioma cell migration. J Biol Chem. 2013;288:343–354.
   PubMed Web of Science ®Google Scholar
• Zhao C, Fancy SP, Franklin RJ, et al. Up-regulation of oligodendrocyte precursor cell alphaV integrin and its extracellular ligands during central nervous system remyelination. J Neurosci Res. 2009;87:3447–3455.
   PubMed Web of Science ®Google Scholar
• Huo Y, Yin XL, Ji SX, et al. Inhibition of retinal ganglion cell axonal outgrowth through the Amino-Nogo-A signaling pathway. Neurochem Res. 2013;38:1365–1374.
   PubMed Web of Science ®Google Scholar
• Baron W, Colognato H, ffrench-Constant C. Integrin-growth factor interactions as regulators of oligodendroglial development and function. Glia 2005;49:467–479.
   PubMed Web of Science ®Google Scholar
• Gudz TI, Komuro H, Macklin WB. Glutamate stimulates oligodendrocyte progenitor migration mediated via an alphav integrin/myelin proteolipid protein complex. J Neurosci. 2006;26:2458–2466.
   PubMed Web of Science ®Google Scholar
• Romaris M, Bassols A, David G. Effect of transforming growth factor-beta 1 and basic fibroblast growth factor on the expression of cell surface proteoglycans in human lung fibroblasts. Enhanced glycanation and fibronectin-binding of CD44 proteoglycan, and down-regulation of glypican. Biochem J. 1995;310 (Pt 1):73–81.
   PubMed Web of Science ®Google Scholar
• Bernfield M, Gotte M, Park PW, et al. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem. 1999;68:729–777.
   PubMed Web of Science ®Google Scholar
• Worapamorn W, Haase HR, Li H, et al. Growth factors and cytokines modulate gene expression of cell-surface proteoglycans in human periodontal ligament cells. J Cell Physiol. 2001;186:448–456.
   PubMed Web of Science ®Google Scholar
• Nikolova V, Koo CY, Ibrahim SA, et al. Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression. Carcinogenesis. 2009;30:397–407.
   PubMed Web of Science ®Google Scholar
• Shimada K, Nakamura M, De Velasco MA, et al. Role of syndecan-1 (CD138) in cell survival of human urothelial carcinoma. Cancer Sci. 2010;101:155–160.
   PubMed Web of Science ®Google Scholar
• Ju Ha H, Kim SJ. Association of insulin receptor and syndecan-1 by insulin with activation of ERK I/II in osteoblast-like UMR-106 cells. J Recept Signal Transduct Res. 2013;33:37–40.
   PubMed Web of Science ®Google Scholar
• Patterson AM, Gardner L, Shaw J, et al. Induction of a CXCL8 binding site on endothelial syndecan-3 in rheumatoid synovium. Arthritis Rheum. 2005;52:2331–2342.
   PubMed Web of Science ®Google Scholar
• Inatani M, Haruta M, Honjo M, et al. Upregulated expression of N-syndecan, a transmembrane heparan sulfate proteoglycan, in differentiated neural stem cells. Brain Res. 2001;920:217–221.
   PubMed Web of Science ®Google Scholar
• Raulo E, Chernousov MA, Carey DJ, et al. Isolation of a neuronal cell surface receptor of heparin binding growth-associated molecule (HB-GAM). Identification as N-syndecan (syndecan-3). J Biol Chem. 1994;269:12999–13004.
   PubMed Web of Science ®Google Scholar
• Lauri SE, Kaukinen S, Kinnunen T, et al. Reg1ulatory role and molecular interactions of a cell-surface heparan sulfate proteoglycan (N-syndecan) in hippocampal long-term potentiation. J Neurosci. 1999;19:1226–1235.
   PubMed Web of Science ®Google Scholar